Stem cell transplant for geriatric ALL

Future horizons in ALL: What should we expect?

Targets for therapy in ETP-ALL

The role of autologous transplant in ALL

Next steps for treating breast cancer

Epirubicin and cyclophosphamide before docetaxel in early breast cancer

neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer

PARP inhibitory velaparib trialled in BRCA1/2 breast cancer

PD-1 therapy with eribulin for triple negative MBC

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer

Extended adjuvant endrocine therapy with letrozole after aromatase inhibition

Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma